Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer | INTERNATIONAL JOURNAL OF CANCER |